[评价伊克萨佐米布相对剂量强度的IRd治疗老年患者复发性或耐药性多发性骨髓瘤:初步研究]
Tomoe Kanda1, Michio Kimura1, Tomoki Sugiyama1
1Department of Pharmacy, Ogaki Municipal Hospital.
概括
接受ixazomib (IXA) 的日本老年患者在IRd治疗中因胃肠道副作用而降低了相对剂量强度 (RDI). 标准的4mg伊克萨佐米布剂量可能对老年人来说不太耐受.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54